Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,586,623
-
Total 13F shares
-
1,077,025
-
Share change
-
+64,939
-
Total reported value
-
$7,869,850
-
Price per share
-
$7.40
-
Number of holders
-
13
-
Value change
-
+$538,496
-
Number of buys
-
8
-
Number of sells
-
2
Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q2 2021
As of 30 Jun 2021,
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,077,025 shares.
The largest 10 holders included
AIGH Capital Management LLC, Roumell Asset Management, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, BlackRock Inc., Minot Wealth Management LLC, PERRITT CAPITAL MANAGEMENT INC, UBS Group AG, WELLS FARGO & COMPANY/MN, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.